Request Free Sample ×
South America Heart Pump Devices Market Infographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

South America Heart Pump Devices Market

ID: MRFR/HC/52756-HCR
200 Pages
Nidhi Mandole
Last Updated: February 06, 2026

South America Heart Pump Devices Market Research Report: By Product (Ventricular Assist Devices, Left Ventricular Assist Devices, Right Ventricular Assist Devices, Bi- Ventricular Assist Devices, Percutaneous Ventricular Assist Devices, Transcutaneous Ventricular Assist Devices, Intra-Aortic Balloon Pumps, Total Artificial Heart), By Device Type (Implantable Heart Pump Devices, Extracorporeal Heart Pump Devices), By Therapy (Bridge-to-candidacy (BTC), Bridge-to-transplant (BTC), Destination Therapy (DT), Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Research Institutes, Others) andBy Regional (Brazil, Mexico, Argentina, Rest of South America) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

South America Heart Pump Devices Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Product (USD Million)
      1. 4.1.1 Ventricular assist devices
      2. 4.1.2 Left ventricular assist devices
      3. 4.1.3 Right ventricular assist devices
      4. 4.1.4 Bi-ventricular assist devices
      5. 4.1.5 Percutaneous ventricular assist devices
      6. 4.1.6 Transcutaneous ventricular assist devices
      7. 4.1.7 Intra-Aortic balloon pumps
      8. 4.1.8 Total artificial heart
    2. 4.2 Healthcare, BY Device Type (USD Million)
      1. 4.2.1 Implantable heart pump devices
      2. 4.2.2 Extracorporeal heart pump devices
    3. 4.3 Healthcare, BY Therapy (USD Million)
      1. 4.3.1 Bridge-to-candidacy (BTC)
      2. 4.3.2 Bridge-to-transplant (BTC)
      3. 4.3.3 Destination therapy (DT)
      4. 4.3.4 Others
    4. 4.4 Healthcare, BY End-User (USD Million)
      1. 4.4.1 Hospitals & Clinics
      2. 4.4.2 Ambulatory surgical centers
      3. 4.4.3 Research institutes
      4. 4.4.4 Others
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Abbott (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Medtronic (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Boston Scientific (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Terumo (JP)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Cleveland Heart (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 CardiacAssist (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Syncardia (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Getinge (SE)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 LivaNova (GB)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 SOUTH AMERICA MARKET ANALYSIS BY PRODUCT
    3. 6.3 SOUTH AMERICA MARKET ANALYSIS BY DEVICE TYPE
    4. 6.4 SOUTH AMERICA MARKET ANALYSIS BY THERAPY
    5. 6.5 SOUTH AMERICA MARKET ANALYSIS BY END-USER
    6. 6.6 KEY BUYING CRITERIA OF HEALTHCARE
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF HEALTHCARE
    9. 6.9 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    11. 6.11 SUPPLY / VALUE CHAIN: HEALTHCARE
    12. 6.12 HEALTHCARE, BY PRODUCT, 2024 (% SHARE)
    13. 6.13 HEALTHCARE, BY PRODUCT, 2024 TO 2035 (USD Million)
    14. 6.14 HEALTHCARE, BY DEVICE TYPE, 2024 (% SHARE)
    15. 6.15 HEALTHCARE, BY DEVICE TYPE, 2024 TO 2035 (USD Million)
    16. 6.16 HEALTHCARE, BY THERAPY, 2024 (% SHARE)
    17. 6.17 HEALTHCARE, BY THERAPY, 2024 TO 2035 (USD Million)
    18. 6.18 HEALTHCARE, BY END-USER, 2024 (% SHARE)
    19. 6.19 HEALTHCARE, BY END-USER, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY PRODUCT, 2025-2035 (USD Million)
      2. 7.2.2 BY DEVICE TYPE, 2025-2035 (USD Million)
      3. 7.2.3 BY THERAPY, 2025-2035 (USD Million)
      4. 7.2.4 BY END-USER, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

South America Healthcare Market Segmentation

Healthcare By Product (USD Million, 2025-2035)

  • Ventricular assist devices
  • Left ventricular assist devices
  • Right ventricular assist devices
  • Bi-ventricular assist devices
  • Percutaneous ventricular assist devices
  • Transcutaneous ventricular assist devices
  • Intra-Aortic balloon pumps
  • Total artificial heart

Healthcare By Device Type (USD Million, 2025-2035)

  • Implantable heart pump devices
  • Extracorporeal heart pump devices

Healthcare By Therapy (USD Million, 2025-2035)

  • Bridge-to-candidacy (BTC)
  • Bridge-to-transplant (BTC)
  • Destination therapy (DT)
  • Others

Healthcare By End-User (USD Million, 2025-2035)

  • Hospitals & Clinics
  • Ambulatory surgical centers
  • Research institutes
  • Others

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓